Medicover AB (publ) (MCOV-B) - Net Assets

Latest as of September 2025: Skr5.76 Billion SEK ≈ $619.73 Million USD

Based on the latest financial reports, Medicover AB (publ) (MCOV-B) has net assets worth Skr5.76 Billion SEK (≈ $619.73 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr25.85 Billion ≈ $2.78 Billion USD) and total liabilities (Skr20.09 Billion ≈ $2.16 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Medicover AB (publ) to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr5.76 Billion
% of Total Assets	22.28%
Annual Growth Rate	17.31%
5-Year Change	1.2%
10-Year Change	425.0%
Growth Volatility	94.22

Medicover AB (publ) - Net Assets Trend (2005–2024)

This chart illustrates how Medicover AB (publ)'s net assets have evolved over time, based on quarterly financial data. Also explore how large is Medicover AB (publ)'s balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Medicover AB (publ) (2005–2024)

The table below shows the annual net assets of Medicover AB (publ) from 2005 to 2024. For live valuation and market cap data, see how much is Medicover AB (publ) worth.

Year	Net Assets	Change
2024-12-31	Skr489.30 Million ≈ $52.66 Million	-7.38%
2023-12-31	Skr528.30 Million ≈ $56.85 Million	+3.43%
2022-12-31	Skr510.80 Million ≈ $54.97 Million	-9.13%
2021-12-31	Skr562.10 Million ≈ $60.49 Million	+16.26%
2020-12-31	Skr483.50 Million ≈ $52.03 Million	+34.42%
2019-12-31	Skr359.70 Million ≈ $38.71 Million	+11.05%
2018-12-31	Skr323.90 Million ≈ $34.86 Million	+6.55%
2017-12-31	Skr304.00 Million ≈ $32.72 Million	+207.69%
2016-12-31	Skr98.80 Million ≈ $10.63 Million	+6.01%
2015-12-31	Skr93.20 Million ≈ $10.03 Million	+2.98%
2014-12-31	Skr90.50 Million ≈ $9.74 Million	+284.31%
2005-12-31	Skr23.55 Million ≈ $2.53 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Medicover AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 15334700000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	Skr73.50 Million	15.81%
Common Stock	Skr30.70 Million	6.60%
Other Comprehensive Income	Skr-56.70 Million	-12.20%
Other Components	Skr417.30 Million	89.78%
Total Equity	Skr464.80 Million	100.00%

Medicover AB (publ) Competitors by Market Cap

The table below lists competitors of Medicover AB (publ) ranked by their market capitalization.

Company	Market Cap
Dis-Chem Pharmacies JSE:DCP	$1.66 Billion
Zhejiang CONBA Pharmaceutical Co Ltd SHG:600572	$1.66 Billion
Sionna Therapeutics, Inc. Common Stock NASDAQ:SION	$1.66 Billion
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	$1.66 Billion
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	$1.66 Billion
TX Group AG SW:TXGN	$1.66 Billion
Syndax Pharmaceuticals Inc NASDAQ:SNDX	$1.66 Billion
Guangdong Yizumi Precision Machinery Co Ltd SHE:300415	$1.66 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medicover AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 496,500,000 to 464,800,000, a change of -31,700,000 (-6.4%).
Net income of 16,700,000 contributed positively to equity growth.
Dividend payments of 18,000,000 reduced retained earnings.
Other comprehensive income increased equity by 63,700,001.
Other factors decreased equity by 94,100,001.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Skr16.70 Million	+3.59%
Dividends Paid	Skr18.00 Million	-3.87%
Other Comprehensive Income	Skr63.70 Million	+13.7%
Other Changes	Skr-94.10 Million	-20.25%
Total Change	Skr-	-6.38%

Book Value vs Market Value Analysis

This analysis compares Medicover AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 67.05x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 312.27x to 67.05x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	Skr0.66	Skr207.50	x
2015-12-31	Skr0.67	Skr207.50	x
2016-12-31	Skr0.96	Skr207.50	x
2017-12-31	Skr2.52	Skr207.50	x
2018-12-31	Skr2.40	Skr207.50	x
2019-12-31	Skr2.38	Skr207.50	x
2020-12-31	Skr3.16	Skr207.50	x
2021-12-31	Skr3.49	Skr207.50	x
2022-12-31	Skr3.19	Skr207.50	x
2023-12-31	Skr3.32	Skr207.50	x
2024-12-31	Skr3.09	Skr207.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medicover AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 3.59%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.80%
• Asset Turnover: 0.98x
• Equity Multiplier: 4.60x
Recent ROE (3.59%) is below the historical average (6.66%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	5.95%	2.37%	1.46x	1.72x	Skr-952.90K
2014	4.85%	1.18%	1.35x	3.04x	Skr-4.56 Million
2015	8.41%	1.80%	1.33x	3.51x	Skr-1.42 Million
2016	4.64%	0.86%	1.19x	4.53x	Skr-4.97 Million
2017	6.23%	3.22%	1.15x	1.68x	Skr-11.33 Million
2018	7.70%	3.66%	1.10x	1.91x	Skr-7.34 Million
2019	7.09%	2.66%	0.83x	3.21x	Skr-9.24 Million
2020	5.76%	2.59%	0.90x	2.48x	Skr-19.00 Million
2021	19.67%	7.39%	0.82x	3.25x	Skr50.04 Million
2022	2.49%	0.78%	0.82x	3.86x	Skr-35.67 Million
2023	3.54%	1.01%	0.90x	3.91x	Skr-32.05 Million
2024	3.59%	0.80%	0.98x	4.60x	Skr-29.78 Million

Industry Comparison

This section compares Medicover AB (publ)'s net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $3,176,058,000
Average return on equity (ROE) among peers: -6.76%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Medicover AB (publ) (MCOV-B)	Skr5.76 Billion	5.95%	3.49x	$1.66 Billion
Ambea AB (AMBEA)	$4.99 Billion	12.43%	2.71x	$1.24 Billion
Attendo AB (publ) (ATT)	$4.96 Billion	1.13%	3.25x	$1.66 Billion
Humana AB (publ) (HUM)	$2.74 Billion	7.67%	2.58x	$252.31 Million
ProstaLund AB (PLUN)	$22.23 Million	-48.25%	0.19x	$716.78K

About Medicover AB (publ)

ST:MCOV-B Sweden Medical Care Facilities

Market Cap

$1.66 Billion

Skr15.44 Billion SEK

Market Cap Rank

#6949 Global

#96 in Sweden

Share Price

Skr207.50

Change (1 day)

-1.19%

52-Week Range

Skr182.20 - Skr285.50

All Time High

Skr369.18